Elevated liver enzyme levels are one of the leading indicators of chronic liver disease, and a new test for the liver can detect it.
The new test is a new blood test that is meant to help athletes and others who are concerned about their liver health, according to a study published today in the journal JAMA Internal Medicine.
Researchers tested 821 men and women for liver enzyme values and found that the average value of those results was 6.4.
“The average value was 6,” Dr. Michael C. Goggin, a professor of medicine at Harvard Medical School and lead author of the study, told The Associated Press.
“It’s not a surprise that it’s higher.
The study also showed that the test was more sensitive than other methods, and that it was more accurate for detecting elevated levels of liver enzymes. “
What’s really surprising is the fact that we saw it in the younger and younger age group.”
The study also showed that the test was more sensitive than other methods, and that it was more accurate for detecting elevated levels of liver enzymes.
The researchers said the results are important because “the risk of elevated liver enzyme is associated with elevated liver function.”
Liver enzymes are a protein that is produced by the liver.
They are the building blocks of many proteins in the body, including the hormone insulin, the hormone leptin and the enzyme that breaks down sugar.
They also help regulate blood sugar and fat levels.
People with high levels of those enzymes are at higher risk of developing liver disease.
“These results may be of interest to those with liver disease who are taking anti-coagulants and those with chronic liver conditions,” Drs.
William C. Miller and Joseph S. Feschuk wrote in the study.
They noted that in older people, liver enzyme tests can be unreliable because they do not take into account age-related changes in the liver’s function.
In the study by Goggen and colleagues, those results were consistent across a variety of liver enzyme markers.
The test, which measures liver enzymes by measuring the amount of an enzyme that is called carnitine palmitoyltransferase (CPT), can be done in the hospital and can detect levels of the enzyme as high as 11 to 14 times higher than the typical healthy person’s level.
But because of the test’s sensitivity, the test can only detect the highest levels of an elevated liver metabolite.
Dr. Steven M. Johnson, director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), told the AP that elevated liver levels are a cause for concern for people with liver diseases.
“Our patients are at high risk for a range of chronic conditions including cirrhosis, liver cancer, type 2 diabetes, elevated liver disease and elevated blood pressure,” he said.
“If we can find a way to lower these levels and lower their risks, we can prevent these conditions from becoming chronic.”
The test can be administered at home or at a doctor’s office and has been shown to be more accurate than other blood tests.
Guggin told the Associated Press that the new test could help athletes who are worried about their health because it could provide them with a more reliable assessment of their liver function.
He said the test could also be used to screen for liver problems in people who have had an abnormal liver function test or are on anticoagulant medication, as well as people who are already taking medication for other conditions.
The results of the trial are based on blood tests taken from 821 people between the ages of 21 and 59.
The study was funded by the National Institutes of Health, and the study was presented at the annual meeting of the American College of Sports Medicine.
The Associated News has reached out to Gogge for comment.